keyword
https://read.qxmd.com/read/31477575/modulation-of-tor-complex-2-signaling-by-the-stress-activated-mapk-pathway-in-fission-yeast
#41
JOURNAL ARTICLE
Susumu Morigasaki, Lit Chein Chin, Tomoyuki Hatano, Midori Emori, Mika Iwamoto, Hisashi Tatebe, Kazuhiro Shiozaki
Sin1 is a substrate-binding subunit of Target Of Rapamycin Complex 2 (TORC2), an evolutionarily conserved protein kinase complex. In fission yeast, Sin1 was also identified as a protein that interacts with Spc1/Sty1 stress-activated protein kinase (SAPK) and therefore, this study examined the relationship between TORC2 and Spc1 signaling. We found that the common docking (CD) domain of Spc1 interacts with a cluster of basic amino acid residues in Sin1. Although diminished TORC2 activity in the absence of the functional Spc1 cascade suggests positive regulation of TORC2 by Spc1, such regulation appears to be independent of the Sin1-Spc1 interaction...
September 2, 2019: Journal of Cell Science
https://read.qxmd.com/read/31286062/control-of-biosilica-morphology-and-mechanical-performance-by-the-conserved-diatom-gene-silicanin-1
#42
JOURNAL ARTICLE
Stefan Görlich, Damian Pawolski, Igor Zlotnikov, Nils Kröger
The species-specifically patterned biosilica cell walls of diatoms are paradigms for biological mineral morphogenesis and the evolution of lightweight materials with exceptional mechanical performance. Biosilica formation is a membrane-mediated process that occurs in intracellular compartments, termed silica deposition vesicles (SDVs). Silicanin-1 (Sin1) is a highly conserved protein of the SDV membrane, but its role in biosilica formation has remained elusive. Here we generate Sin1 knockout mutants of the diatom Thalassiosira pseudonana ...
2019: Communications Biology
https://read.qxmd.com/read/31142514/mtorc2-suppresses-gsk3-dependent-snail-degradation-to-positively-regulate-cancer-cell-invasion-and-metastasis
#43
JOURNAL ARTICLE
Shuo Zhang, Guoqing Qian, Qian-Qian Zhang, Yuying Yao, Dongsheng Wang, Zhuo Georgia Chen, Li-Jing Wang, Mingwei Chen, Shi-Yong Sun
Mammalian target of rapamycin (mTOR) complex 1 (mTORC1) positively regulates cell invasion and metastasis by enhancing translation of Snail. A connection between mTOR complex 2 (mTORC2) and cell invasion and metastasis has also been suggested, yet the underlying biology or mechanism is largely unknown and thus is the focus of this study. Inhibition of mTOR with both mTOR inhibitors and knockdown of key components of mTORC, including rictor, Sin1 and raptor, decreased Snail protein levels. Inhibition of mTOR enhanced the rate of Snail degradation, which could be rescued by inhibition of the proteasome...
May 29, 2019: Cancer Research
https://read.qxmd.com/read/31010692/diverse-signaling-mechanisms-of-mtor-complexes-mtorc1-and-mtorc2-in-forming-a-formidable-relationship
#44
REVIEW
Meena Jhanwar-Uniyal, John V Wainwright, Avinash L Mohan, Michael E Tobias, Raj Murali, Chirag D Gandhi, Meic H Schmidt
Activation of Mechanistic target of rapamycin (mTOR) signaling plays a crucial role in tumorigenesis of numerous malignancies including glioblastoma (GB). The Canonical PI3K/Akt/mTOR signaling cascade is commonly upregulated due to loss of the tumor suppressorm PTEN, a phosphatase that acts antagonistically to the kinase (PI3K) in conversion of PIP2 to PIP3. mTOR forms two multiprotein complexes, mTORC1 and mTORC2 which are composed of discrete protein binding partners to regulate cell growth, motility, and metabolism...
May 2019: Advances in Biological Regulation
https://read.qxmd.com/read/30847386/nitidine-chloride-inhibits-sin1-expression-in-osteosarcoma-cells
#45
JOURNAL ARTICLE
Hui Xu, Tong Cao, Xiaoqing Zhang, Ying Shi, Qing Zhang, Shuo Chai, Li Yu, Guoxi Jin, Jia Ma, Peter Wang, Yuyun Li
Nitidine chloride (NC) has been demonstrated to exert a tumor-suppressive function in various types of human cancers. However, the detailed mechanism of NC-mediated anti-tumor effects remains elusive. It has been reported that SIN1, a component of mTORC2 (mammalian target of rapamycin complex C2), plays an oncogenic role in a variety of human cancers. Therefore, the inhibition of SIN1 could be useful for the treatment of human cancers. In this study, we explored whether NC triggered an anti-cancer function via the inhibition of SIN1 in osteosarcoma (OS) cells...
March 29, 2019: Molecular Therapy Oncolytics
https://read.qxmd.com/read/30837283/phosphorylation-at-distinct-subcellular-locations-underlies-specificity-in-mtorc2-activation-of-sgk1-and-akt
#46
JOURNAL ARTICLE
Catherine E Gleason, Juan A Oses-Prieto, Kathy H Li, Bidisha Saha, Gavin Situ, Alma L Burlingame, David Pearce
mTORC2 lies at the intersection of signaling pathways that control metabolism and ion transport through phosphorylation of the AGC-family kinases, Akt and SGK1. How mTORC2 targets these functionally distinct downstream effectors in a context-specific manner is not known. Here, we show that the salt- and blood pressure-regulatory hormone, angiotensin II stimulates selective mTORC2-dependent phosphorylation of SGK1 (S422) but not Akt (S473). Conventional PKC (cPKC), a critical mediator of AT1 R signaling, regulates the subcellular localization of SIN1 and SGK1...
March 5, 2019: Journal of Cell Science
https://read.qxmd.com/read/30783264/author-correction-sin1-phosphorylation-impairs-mtorc2-complex-integrity-and-inhibits-downstream-akt-signalling-to-suppress-tumorigenesis
#47
JOURNAL ARTICLE
Pengda Liu, Wenjian Gan, Hiroyuki Inuzuka, Adam S Lazorchak, Daming Gao, Omotooke Arojo, Dou Liu, Lixin Wan, Bo Zhai, Yonghao Yu, Min Yuan, Byeong Mo Kim, Shavali Shaik, Suchithra Menon, Steven P Gygi, Tae Ho Lee, John M Asara, Brendan D Manning, John Blenis, Bing Su, Wenyi Wei
In the version of this Article originally published, the labels for Rictor and mTOR in the whole cell lysate (WCL) blots were swapped in Fig. 3b and the mTOR blot was placed upside down. Unprocessed blots of mTOR were also missing from Supplementary Fig. 9. The corrected Figs are shown below. In addition, control blots for the mTOR antibody (Cell Signalling Technology #2972) were also missing. These are now provided below, as Fig. 9, and show that the lower band is likely non-specific.
May 2019: Nature Cell Biology
https://read.qxmd.com/read/30705387/sin1-mtorc2-regulate-b-cell-growth-and-metabolism-by-activating-mtorc1-and-myc
#48
JOURNAL ARTICLE
Man Li, Adam S Lazorchak, Xinxing Ouyang, Huihui Zhang, Hongzhi Liu, Omotooke A Arojo, Lichong Yan, Jingsi Jin, Yuheng Han, Guojun Qu, Yuhong Fu, Xiaocao Xu, Xiaobo Liu, Wenqian Zhang, Zhengfeng Yang, Chuan Ruan, Qijun Wang, Dou Liu, Chuanxin Huang, Lu Lu, Shibo Jiang, Fubin Li, Bing Su
Proper control of B cell growth and metabolism is crucial for B-cell-mediated immunity, but the underlying molecular mechanisms remain incompletely understood. In this study, Sin1, a key component of mTOR complex 2 (mTORC2), specifically regulates B cell growth and metabolism. Genetic ablation of Sin1 in B cells reduces the cell size at either the transitional stage or upon antigen stimulation and severely impairs metabolism. Sin1 deficiency also severely impairs B-cell proliferation, antibody responses, and anti-viral immunity...
January 31, 2019: Cellular & Molecular Immunology
https://read.qxmd.com/read/30587525/identification-and-targeting-of-novel-cdk9-complexes-in-acute-myeloid-leukemia
#49
JOURNAL ARTICLE
Elspeth M Beauchamp, Sameem M Abedin, Sara G Radecki, Mariafausta Fischietti, Ahmet Dirim Arslan, Gavin T Blyth, Angela Yang, Connor Lantz, Alissa Nelson, Young Ah Goo, Imo Akpan, Elizabeth A Eklund, Olga Frankfurt, Eleanor N Fish, Paul M Thomas, Jessica K Altman, Leonidas C Platanias
Aberrant activation of mTOR signaling in acute myeloid leukemia (AML) results in a survival advantage that promotes the malignant phenotype. To improve our understanding of factors that contribute to mTOR signaling activation and identify novel therapeutic targets, we searched for unique interactors of mTOR complexes through proteomics analyses. We identify cyclin dependent kinase 9 (CDK9) as a novel binding partner of the mTOR complex scaffold protein, mLST8. Our studies demonstrate that CDK9 is present in distinct mTOR-like (CTOR) complexes in the cytoplasm and nucleus...
December 26, 2018: Blood
https://read.qxmd.com/read/30571167/sin1-stress-activated-protein-kinase-interacting-protein-regulates-ischemia-induced-microthrombosis-through-integrin-%C3%AE-iib%C3%AE-3-mediated-outside-in-signaling-and-hypoxia-responses-in-platelets
#50
JOURNAL ARTICLE
Yanyan Xu, Xinxing Ouyang, Lichong Yan, Mingliang Zhang, Zhenlei Hu, Jianmin Gu, Xuemei Fan, Lin Zhang, Junfeng Zhang, Song Xue, Guoqiang Chen, Bing Su, Junling Liu
Objective- Microthrombosis as a serious consequence of myocardial infarction, impairs the microvascular environment and increases the occurrences of heart failure, arrhythmia, and death. Sin1 (stress-activated protein kinase-interacting protein) as an essential component of mTORC2 (mammalian target of rapamycin complex 2) is required for cell proliferation and metabolism in response to nutrients, stress, and reactive oxygen species and activates Akt and PKC (protein kinase C). However, the activation and function of Sin1/mTORC2 in ischemia-induced microthrombosis remain poorly understood...
December 2018: Arteriosclerosis, Thrombosis, and Vascular Biology
https://read.qxmd.com/read/30496428/sin1-mtorc2-signaling-drives-glycolysis-of-developing-thymocytes
#51
JOURNAL ARTICLE
Hongbo Chi
No abstract text is available yet for this article.
November 29, 2018: Journal of Molecular Cell Biology
https://read.qxmd.com/read/30428057/metabolic-regulation-of-t-cell-development-by-sin1-mtorc2-is-mediated-by-pyruvate-kinase-m2
#52
JOURNAL ARTICLE
Xinxing Ouyang, Yuheng Han, Guojun Qu, Man Li, Omotooke Arojo, Hongxiang Sun, Xiaobo Liu, Dou Liu, Lei Chen, Qiang Zou, Bing Su
Glucose metabolism plays a key role in thymocyte development. The mammalian target of rapamycin complex 2 (mTORC2) is a critical regulator of cell growth and metabolism, but its role in early thymocyte development and metabolism has not been fully studied. We show here that genetic ablation of Sin1, an essential component of mTORC2, in T lineage cells results in severely impaired thymocyte development at the CD4-CD8- double negative (DN) stages but not at the CD4+CD8+ double positive (DP) or later stages. Notably, Sin1-deficient DN thymocytes show markedly reduced proliferation and glycolysis...
November 14, 2018: Journal of Molecular Cell Biology
https://read.qxmd.com/read/30217824/c-jun-n-terminal-kinase-jnk-mediated-induction-of-msin1-expression-and-mtorc2-activation-in-mesenchymal-cells-during-fibrosis
#53
JOURNAL ARTICLE
Natalie M Walker, Serina M Mazzoni, Ragini Vittal, Diane C Fingar, Vibha N Lama
Mammalian target of rapamycin complex 2 (mTORC2) has been shown to regulate mTORC1/4E-BP1/eIF4E signaling and collagen I expression in mesenchymal cells (MCs) during fibrotic activation. Here we investigated the regulation of the mTORC2 binding partner mammalian stress-activated protein kinase-interacting protein 1 (mSin1) in MCs derived from human lung allografts and identified a novel role for mSin1 during fibrosis. mSin1 was identified as a common downstream target of key fibrotic pathways, and its expression was increased in MCs in response to pro-fibrotic mediators: lysophosphatidic acid (LPA), transforming growth factor β, and interleukin 13...
November 2, 2018: Journal of Biological Chemistry
https://read.qxmd.com/read/30187764/does-reinke-s-edema-grade-determine-premalignant-potential
#54
JOURNAL ARTICLE
Raluca Tavaluc, Howard Herman, Juan Lin, Melin Tan
OBJECTIVE: Reinke's edema (RE) is a benign disease of the vocal folds with a wide spectrum of clinical severity. We aim to evaluate the clinical impact of RE grade and determine if RE grade correlates with severity of dysplasia and tobacco exposure. METHODS: Patients with isolated RE who underwent surgical excision between December 2010 and December 2014 were retrospectively reviewed. The RE grade was determined from archived laryngeal videostroboscopy exams. Pathologic severity of dysplasia, categorized by squamous intraepithelial neoplasia (SIN) classification, and tobacco history were extracted from medical records...
November 2018: Annals of Otology, Rhinology, and Laryngology
https://read.qxmd.com/read/29934471/active-mtorc2-signaling-in-naive-t-cells-suppresses-bone-marrow-homing-by-inhibiting-cxcr4-expression
#55
JOURNAL ARTICLE
Omotooke A Arojo, Xinxing Ouyang, Dou Liu, Ting Meng, Susan M Kaech, Joao P Pereira, Bing Su
Recirculation of naive T cells between secondary lymphoid organs to receive survival cues and scan for signs of infection or other pathologic conditions is important for immune homeostasis and effective immune responses. Although the mechanisms that specifically guide the entry of naive T cells into secondary lymphoid organs are well studied, the mechanisms that keep them from fluxing into inappropriate or undesirable compartments, such as healthy tissues or bone marrow, are less well understood. In this study, we report an unexpected finding that under steady state, bone marrow homing of naive T cells is actively suppressed by mTORC2 signaling...
August 1, 2018: Journal of Immunology
https://read.qxmd.com/read/29445114/kinesin-1-regulates-cilia-length-through-an-interaction-with-the-bardet-biedl-syndrome-related-protein-ccdc28b
#56
JOURNAL ARTICLE
Rossina Novas, Magdalena Cardenas-Rodriguez, Paola Lepanto, Matías Fabregat, Magela Rodao, María Inés Fariello, Mauricio Ramos, Camila Davison, Gabriela Casanova, Lucía Alfaya, Federico Lecumberry, Gualberto González-Sapienza, Florencia Irigoín, Jose L Badano
Bardet-Biedl syndrome (BBS) is a ciliopathy characterized by retinal degeneration, obesity, polydactyly, renal disease and mental retardation. CCDC28B is a BBS-associated protein that we have previously shown plays a role in cilia length regulation whereby its depletion results in shortened cilia both in cells and Danio rerio (zebrafish). At least part of that role is achieved by its interaction with the mTORC2 component SIN1, but the mechanistic details of this interaction and/or additional functions that CCDC28B might play in the context of cilia remain poorly understood...
February 14, 2018: Scientific Reports
https://read.qxmd.com/read/29184034/mek-inhibitor-trametinib-does-not-prevent-the-growth-of-anaplastic-lymphoma-kinase-alk-addicted-neuroblastomas
#57
JOURNAL ARTICLE
Ganesh Umapathy, Jikui Guan, Dan E Gustafsson, Niloufar Javanmardi, Diana Cervantes-Madrid, Anna Djos, Tommy Martinsson, Ruth H Palmer, Bengt Hallberg
Activation of the RAS-RAF-MEK-ERK signaling pathway is implicated in driving the initiation and progression of multiple cancers. Several inhibitors targeting the RAS-MAPK pathway are clinically approved as single- or polyagent therapies for patients with specific types of cancer. One example is the MEK inhibitor trametinib, which is included as a rational polytherapy strategy for treating EML4-ALK-positive, EGFR-activated, or KRAS-mutant lung cancers and neuroblastomas that also contain activating mutations in the RAS-MAPK pathway...
November 28, 2017: Science Signaling
https://read.qxmd.com/read/29156676/uncoupling-torc2-from-agc-kinases-inhibits-tumour-growth
#58
JOURNAL ARTICLE
Angus J M Cameron, Selvaraju Veeriah, Jacqueline J T Marshall, Elizabeth R Murray, Banafshé Larijani, Peter J Parker
Mammalian target of rapamycin (mTOR) is a central regulator of growth and metabolism. mTOR resides in two distinct multi-protein complexes - mTORC1 and mTORC2 - with distinct upstream regulators and downstream targets. While it is possible to specifically inhibit mTORC1 with rapamycin, or inhibit both mTOR complexes together with ATP pocket directed mTOR kinase inhibitors, it is not possible to assess the specific roles for mTORC2 pharmacologically. To overcome this, we have developed a novel, inducible, dominant negative system for disrupting substrate recruitment to mTORC2...
October 17, 2017: Oncotarget
https://read.qxmd.com/read/29104218/evolutionary-conservation-of-the-components-in-the-tor-signaling-pathways
#59
REVIEW
Hisashi Tatebe, Kazuhiro Shiozaki
Target of rapamycin (TOR) is an evolutionarily conserved protein kinase that controls multiple cellular processes upon various intracellular and extracellular stimuli. Since its first discovery, extensive studies have been conducted both in yeast and animal species including humans. Those studies have revealed that TOR forms two structurally and physiologically distinct protein complexes; TOR complex 1 (TORC1) is ubiquitous among eukaryotes including animals, yeast, protozoa, and plants, while TOR complex 2 (TORC2) is conserved in diverse eukaryotic species other than plants...
November 1, 2017: Biomolecules
https://read.qxmd.com/read/28934384/short-syndrome-due-to-a-novel-de-novo-mutation-in-prkce-protein-kinase-c%C3%A9-impairing-torc2-dependent-akt-activation
#60
JOURNAL ARTICLE
Diana Alcantara, Frances Elmslie, Martine Tetreault, Eric Bareke, Taila Hartley, Jacek Majewski, Kym Boycott, A Micheil Innes, David A Dyment, Mark O'Driscoll
SHORT syndrome is a rare, recognizable syndrome resulting from heterozygous mutations in PIK3R1 encoding a regulatory subunit of phosphoinositide-3-kinase (PI3K). The condition is characterized by short stature, intrauterine growth restriction, lipoatrophy and a facial gestalt involving a triangular face, deep set eyes, low hanging columella and small chin. PIK3R1 mutations in SHORT syndrome result in reduced signaling through the PI3K-AKT-mTOR pathway. We performed whole exome sequencing for an individual with clinical features of SHORT syndrome but negative for PIK3R1 mutation and her parents...
October 1, 2017: Human Molecular Genetics
keyword
keyword
85180
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.